Kynac safingol ointment: Began Phase II trials

Sphinx Pharmaceuticals Corp. (SPHX) Product: Kynac safingol ointment, inhibitor of protein kinase C Indication: Atopic dermatitis Status: Began Phase II trials in 50-75 patients ...